RA Rodby, LM Firth, EJ Lewis - Diabetes Care, 1996 - Am Diabetes Assoc OBJECTIVE: The results of a recent clinical trial. The Effect of ACE inhibition
on Diabetic Nephropathy, demonstrated that captopril reduced the rate of renal
failure, end-stage renal disease (ESRD), and death in patients with IDDM ... Cited by 65 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org [PDF] BM Hendry, GC Viberti, S Hummel, A Bagust, … - QJM, 1997 - Oxford Univ Press Modelling and costing the consequences of using an ACE ... BM HENDRY, GC
VIBERTI1, S. HUMMEL2, A. BAGUST2 and J. PIERCY2 ... From the Renal Group,
Department of Medicine, King's College School of Medicine and Dentistry, ... Cited by 24 - Related articles - BL Direct - All 4 versions
- ►canadianmedicaljournal.ca WF Clark, DN Churchill, L Forwell, G … - Canadian Medical Association Journal, 2000 - Can Med Assoc Results: Compared with a no-payment strategy, provincial payment of ACE
inhibitor therapy was found to be highly cost-effective: it resulted in an
increase of 0.147 in the number of quality-adjusted life-years (QALYs) and ... Cited by 46 - Related articles - BL Direct - All 16 versions
P Ruggenenti, E Pagano, L Tammuzzo, R … - Kidney international, 2001 - nature.com Kidney International aims to inform the renal researcher and practicing nephrologists
on all aspects of renal research. Clinical and basic renal research, commentaries ... Cited by 32 - Related articles - BL Direct - All 4 versions
RA Rodby, CF Chiou, J Borenstein, A … - Clinical therapeutics, 2003 - Elsevier Methods: Three treatments for hypertensioe patients with type 2 diabetes
mellitus and nephropathy were assessed: (1) irbesartan, (2) amlodipine, and (3)
placebo. A Markov model was developed based on primary data from the ... Cited by 35 - Related articles - All 5 versions
- Free from Publisher WH Herman, S Shahinfar, GW Carides, EJ … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—The Reduction of End Points in Type 2 Diabetes
With the Angiotensin II Antagonist Losartan (RENAAL) study was a multinational
double-blind randomized placebo-controlled clinical trial designed to ... Cited by 64 - Related articles - BL Direct - All 7 versions
PK Schadlich, JG Brecht, M Brunetti, E … - Pharmacoeconomics, 2001 - ingentaconnect.com 1 InForMed GmbH – Outcomes Research & Health Economics, Ingolstadt, Germany 2
Centro per la Valuazione della Efficacia della Assistenza Sanitaria (CEVEAS),
Modena, Italy 3 Progetto Sperimentazione Gestazionale, Azienda Ospedaliera ... Cited by 26 - Related articles - BL Direct - All 3 versions
L Garattini, M Brunetti, F Salvioni, M Barosi - Pharmacoeconomics, 1997 - ncbi.nlm.nih.gov Diabetic nephropathy is one of the major complications of insulin-dependent
diabetes mellitus (IDDM), with proteinuria being the main clinical manifestation
of diabetic nephropathy. Most patients who develop overt proteinuria ... Cited by 9 - Related articles - BL Direct - All 3 versions
- ►bmj.com [PDF] K Borch-Johnsen, H Wenzel, GC Viberti, CE … - British Medical Journal, 1993 - bmj.com Page 1. doi:10.1136/bmj.306.6894.1722 1993;306;1722-1725 BMJ K Borch-Johnsen,
H Wenzel, GC Viberti and CE Mogensen insulin dependent diabetes? ... Cited by 119 - Related articles - BL Direct - All 5 versions
